The association of endothelin-1 with markers of oxidative stress in a biethnic South African cohort: the SABPA study.
Both endothelin-1 and oxidative stress have important roles in the development of cardiovascular diseases such as hypertension and atherosclerosis. Limited information is available on the interaction between oxidative stress, the glutathione system and endothelin-1 in humans. We aimed to investigate the association of endothelin-1 with markers of oxidative stress and the antioxidant capacity in a biethnic South African cohort. This cross-sectional study included 195 black and 198 white South Africans. Serum endothelin-1 levels and oxidative stress-related markers such as reactive oxygen species (measured as serum peroxides), glutathione peroxidase, glutathione reductase, superoxide dismutase and catalase were measured. In single, partial and multiple regression analyses endothelin-1 correlated positively with glutathione reductase activity (adj. R2=0.10; β=0.232; P=0.020) and negatively with antihypertension medication (P=0.02) and tended to correlate with glutathione reductase-to-glutathione peroxidase ratio (adj. R2=0.10; β=0.19; P=0.057) in black men. In white men, endothelin-1 correlated positively with ROS (adj. R2=0.09; β=0.26; P=0.01) and negatively with glutathione peroxidase activity (adj. R2=0.05; β=-0.23; P=0.02). In black women, endothelin-1 correlated negatively with total glutathione (adj. R2=0.22; β=-0.214; P=0.026). Endothelin-1 may contribute to glutathione reductase upregulation through increased reactive oxygen species production mediated via endothelin-1 in black men. In white men, we observed a negative association between glutathione peroxidase and endothelin-1, describing the expected physiological relationship between endothelin-1 and reactive oxygen species. Higher total glutathione levels may act as a counter-regulatory mechanism to protect against oxidative vascular damage attributed by endothelin-1 in black women.
Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa.
Christine Susara
CS
du Plooy
Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa.
Catharina
C
Martha Cornelia Mels
Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa.|Medical Research Council: Research Unit for Hypertension and Cardiovascular Disease, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa.
Hugo Willem
HW
Huisman
Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa.
Ruan
R
Kruger
D000328:Adult; D015415:Biomarkers / Q000097:blood; D044383:Black People; D001794:Blood Pressure / Q000502:physiology*; D002374:Catalase / Q000097:blood; D002784:Cholesterol / Q000097:blood; D003430:Cross-Sectional Studies; D019332:Endothelin-1 / Q000097:blood*; D005260:Female; D005979:Glutathione Peroxidase / Q000097:blood; D005980:Glutathione Reductase / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D018384:Oxidative Stress / Q000502:physiology*; D017382:Reactive Oxygen Species / Q000097:blood*; D012737:Sex Factors; D013019:South Africa; D013482:Superoxide Dismutase / Q000097:blood; D044465:White People
D015415:Biomarkers; D019332:Endothelin-1; D017382:Reactive Oxygen Species; D002784:Cholesterol; D002374:Catalase; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase; D005980:Glutathione Reductase
Clin Chem. 1972 Jun;18(6):499-502
4337382
Circulation. 2004 Jun 1;109(21):2511-7
15159296
Int J Epidemiol. 2015 Dec;44(6):1814-22
25344943
Basic Res Cardiol. 2000 Apr;95(2):98-105
10826501
J Mol Cell Cardiol. 2000 Aug;32(8):1429-37
10900169
J Membr Biol. 1986;89(1):1-8
2870192
Free Radic Biol Med. 2006 Nov 1;41(9):1384-91
17023265
JAMA. 1995 Oct 4;274(13):1049-57
7563456
Mutat Res. 2007 Jul 10;631(1):55-61
17499011
Eur J Pharmacol. 2009 Mar 1;605(1-3):15-22
19171135
Cardiovasc Res. 1999 Aug 1;43(2):300-7
10536660
Hypertension. 2003 Oct;42(4):811-7
12913063
Am Heart J. 1990 Apr;119(4):801-6
2138844
J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S401-3
11078433
J Amino Acids. 2015;2015:481517
26823980
Atherosclerosis. 2016 May;248:91-6
26990726
Clin Sci (Lond). 2006 Feb;110(2):243-53
16271043
Toxicol Lett. 1995 Dec;82-83:395-8
8597083
J Clin Invest. 1986 Apr;77(4):1370-6
3514679
Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H689-95
21666117
Am J Physiol. 1989 Oct;257(4 Pt 1):L163-73
2572174
J Nutr Biochem. 2005 Oct;16(10):577-86
16111877
Hypertension. 1996 Oct;28(4):652-5
8843893
Age (Dordr). 2016 Feb;38(1):9
26767376
Cardiovasc Res. 2007 Oct 1;76(1):8-18
17617392
Hypertens Res. 2015 Mar;38(3):208-12
25391457
Free Radic Biol Med. 2011 Sep 1;51(5):978-92
21627987
Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H425-32
19465546
Int J Epidemiol. 2012 Aug;41(4):1114-23
22825590
J Cardiovasc Pharmacol. 1990 Oct;16(4):654-60
1706809
Atherosclerosis. 2007 Feb;190(2):408-15
16527283
N Engl J Med. 1991 Oct 3;325(14):997-1001
1886637
Trends Cardiovasc Med. 2007 Feb;17(2):48-54
17292046
Am J Hypertens. 2002 Feb;15(2 Pt 1):164-9
11863252
Hypertension. 2000 Mar;35(3):732-9
10720587
Hypertension. 2003 Jul;42(1):49-55
12782645
Clin Exp Hypertens. 2011;33(8):511-7
21958364
J Am Coll Cardiol. 1994 Aug;24(2):471-6
8034885
Behav Res Methods. 2009 Nov;41(4):1149-60
19897823
Hypertension. 2007 Dec;50(6):1012-8
17954720
Expert Rev Cardiovasc Ther. 2003 May;1(1):91-106
15030300
J Appl Physiol (1985). 1993 May;74(5):2566-73
8335593
Toxicol Sci. 2005 Nov;88(1):265-73
16107552
Trends Pharmacol Sci. 1989 Sep;10(9):374-8
2690429
Clin Chem. 2006 Apr;52(4):601-23
16484333
Am J Hypertens. 2009 Nov;22(11):1154-9
19730419
Circulation. 1995 May 1;91(9):2415-22
7729029
Am J Clin Nutr. 1999 Aug;70(2):252-60
10426703
Hypertension. 2003 Oct;42(4):806-10
12874096
Br J Nutr. 1993 Nov;70(3):797-808
8297917
Am J Hypertens. 2005 Jan;18(1 Pt 2):3S-10S
15683725
J Hum Hypertens. 2012 Feb;26(2):91-7
21270837